CHEMBL116463
| SMILES | N#Cc1ccc(CCOC(=O)NC2CCN(CCCC(c3ccc(F)cc3)c3ccc(F)cc3)CC2)cc1 |
| InChIKey | GALCSZPFCCZIBC-UHFFFAOYSA-N |
Chemical properties
| Hydrogen bond acceptors | 4 |
| Hydrogen bond donors | 1 |
| Rotatable bonds | 10 |
| Molecular weight (Da) | 517.3 |
Drug properties
| Molecular type | Small molecule |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Database connections
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| D5 | DRD5 | Human | Dopamine | A | pIC50 | 6.29 | 6.29 | 6.29 | ChEMBL |
| 5-HT1B | 5HT1B | Human | 5-Hydroxytryptamine | A | pIC50 | 5.45 | 5.45 | 5.45 | ChEMBL |
| V1A | V1AR | Human | Vasopressin and oxytocin | A | pIC50 | 5.44 | 5.44 | 5.44 | ChEMBL |
| H2 | HRH2 | Human | Histamine | A | pIC50 | 6.43 | 6.43 | 6.43 | ChEMBL |
| 5-HT7 | 5HT7R | Human | 5-Hydroxytryptamine | A | pIC50 | 6.0 | 6.0 | 6.0 | ChEMBL |
| H1 | HRH1 | Human | Histamine | A | pIC50 | 6.34 | 6.34 | 6.34 | ChEMBL |
| D4 | DRD4 | Human | Dopamine | A | pIC50 | 6.26 | 6.26 | 6.26 | ChEMBL |
| D1 | DRD1 | Human | Dopamine | A | pIC50 | 6.42 | 6.42 | 6.42 | ChEMBL |
| 5-HT6 | 5HT6R | Human | 5-Hydroxytryptamine | A | pIC50 | 6.37 | 6.37 | 6.37 | ChEMBL |
| 5-HT2C | 5HT2C | Human | 5-Hydroxytryptamine | A | pIC50 | 5.56 | 5.56 | 5.56 | ChEMBL |
| D3 | DRD3 | Human | Dopamine | A | pIC50 | 6.27 | 6.27 | 6.27 | ChEMBL |
| 5-HT2A | 5HT2A | Human | 5-Hydroxytryptamine | A | pIC50 | 6.17 | 6.17 | 6.17 | ChEMBL |
| 5-HT1A | 5HT1A | Human | 5-Hydroxytryptamine | A | pIC50 | 6.01 | 6.01 | 6.01 | ChEMBL |
| δ | OPRD | Human | Opioid | A | pIC50 | 5.24 | 5.24 | 5.24 | ChEMBL |
| A3 | AA3R | Human | Adenosine | A | pIC50 | 5.22 | 5.22 | 5.22 | ChEMBL |
| κ | OPRK | Human | Opioid | A | pIC50 | 5.7 | 5.7 | 5.7 | ChEMBL |
| μ | OPRM | Human | Opioid | A | pIC50 | 5.18 | 5.18 | 5.18 | ChEMBL |
| CB1 | CNR1 | Human | Cannabinoid | A | pIC50 | 5.21 | 5.21 | 5.21 | ChEMBL |
| D2 | DRD2 | Human | Dopamine | A | pIC50 | 6.26 | 6.26 | 6.26 | ChEMBL |